| 1 |
20683637 | A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma. | 2012 Feb |
1 |
| 2 |
16860662 | Inhibitors of the HSP90 molecular chaperone: current status. | 2006 |
1 |
| 3 |
16880941 | Identification of genes involved in the sensitivity to antitumour drug 17-allylamino,17-demethoxygeldanamycin (17AAG). | 2006 May |
1 |
| 4 |
15961763 | Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies. | 2005 Jun 20 |
1 |
| 5 |
14600095 | Magnetic resonance spectroscopic pharmacodynamic markers of the heat shock protein 90 inhibitor 17-allylamino,17-demethoxygeldanamycin (17AAG) in human colon cancer models. | 2003 Nov 5 |
1 |